Cholesterol, a complex and essential lipid, has long been associated with various health issues, particularly high levels linked to heart disease and stroke. However, this tiny molecule, found in every cell, plays a crucial role in our bodies, regulating processes that scientists are still unraveling.
Michael Zott, a researcher at the University of Pennsylvania, highlights the challenges of studying cholesterol due to its minuscule size and difficulty in tracking. To overcome this, scientists often use "functional derivatives" - molecules designed to mimic cholesterol with added chemical tags for visibility.
In a groundbreaking study published in the Journal of the American Chemical Society, Zott and his team, led by Dirk Trauner, have developed a new set of cholesterol proxies with a unique twist - light-sensitive compounds attached. These "photocholesterols" can change shape when exposed to light, allowing researchers to control cholesterol's biological activity.
This innovative approach opens doors to advanced therapeutics, enabling drugs to be activated deep within the body, where traditional methods fall short. The team envisions using specific wavelengths of light that can penetrate the skin to reach targeted organs for treatment.
"The beauty of using light to trigger these molecular changes is its ability to penetrate tissues deeply," explains Trauner. "This spatiotemporal control allows us to activate a drug systemically and then precisely target a specific location with a focused light beam."
Interestingly, the team discovered that not all photocholesterols behaved identically. Some showed a strong preference for certain transport proteins, and one candidate emerged as a potential first selective inhibitor of two poorly understood sterol transport proteins, ORP1 and ORP2.
"Our work has already led to new discoveries," says Luca Laraia, a co-senior author from the Technical University of Denmark. "We now have the first photoswitchable inhibitors of ORP1 and ORP2, proteins critical to cholesterol balance but whose function remains elusive. This will greatly aid our understanding of their biological roles."
Zott adds, "By finding selective molecules for these proteins, we can develop tools to manipulate their activity, which will help uncover their functions."
Looking ahead, the team plans to utilize light's precision to map the movement of key sterol transport proteins within complex cellular models under normal and disease-like conditions. They also aim to apply this computational design strategy to create light-controlled versions of other lipids, with the ultimate goal of optimizing lipid nanoparticle formulations for various applications, including light-controlled mRNA delivery and designing systemic therapies that can be locally activated with focused light beams.
"Cholesterol is integral to biology and underpins cutting-edge tools like lipid nanoparticles used in modern vaccine technology," Zott concludes. "By creating a light-controlled version, we can investigate and potentially enhance these vital processes."
This research not only offers a new perspective on cholesterol but also opens up exciting possibilities for targeted and precise medical interventions.
